ERBB2 and urothelial carcinoma: HER-2 is a key member overexpressed in a variety of cancers, including breast cancer, urothelial carcinoma [29], colorectal cancer [30], and non-small cell lung cancer [31], etc. Activated HER-2 promotes tumor growth and spread [32].